SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Total Liabilities | ₹333 Cr | ₹514 Cr | ₹830 Cr |
What is the latest Total Liabilities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹333 Cr |
| Mar2024 | ₹514 Cr |
| Mar2023 | ₹830 Cr |
How is Total Liabilities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹333 Cr | -35.14 | |
| Mar2024 | ₹514 Cr | -38.11 | |
| Mar2023 | ₹830 Cr | - | |
Compare Total Liabilities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹4,007.6 Cr | -1.1% | -5.6% | -0.1% | Stock Analytics | |
| SAGILITY INDIA | ₹19,347.9 Cr | -8.4% | -19.7% | -10.2% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹16,131.7 Cr | -5.5% | -11.3% | -39.7% | Stock Analytics | |
| LATENT VIEW ANALYTICS | ₹6,528.5 Cr | -5% | -21.7% | -13.8% | Stock Analytics | |
| JUST DIAL | ₹4,453.4 Cr | -6% | -15.9% | -33.8% | Stock Analytics | |
| AWFIS SPACE SOLUTIONS | ₹1,957.4 Cr | -7.3% | -27.4% | -56.4% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -1.1% |
-5.6% |
-0.1% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses